GDRXNasdaqServices-Computer Processing & Data PreparationFiscal year ends December 31

GoodRx Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$3.37+0.01 (+0.30%)

Close on Oct 19, 2026

Market cap: $1.17B
P/E (TTM): 84.3
Dividend yield: –

Dividends

GoodRx has not reported a dividend

No dividend per share appears in GoodRx's annual filings since fiscal 2017.

Where these numbers come from

Parsed from the XBRL in GoodRx's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is GDRX.

Revenue growth-1.8% · median 11.5%

Gross margin90.8% · median 84.5%

Operating margin9.5% · median 11.6%

Net margin2.1% · median 15.1%

Company	Revenue	Growth
CARG	$967.27M	+13.9%
SSTK	$901.29M	-10.8%
NRDS	$860.00M	+11.5%
RAMP	$832.10M	+8.9%
GDRX	$785.23M	-1.8%
HNGE	$720.06M	+49.8%

Company

Next earnings (est.): Nov 3, 2026, after close
Exchange: Nasdaq
Industry: Services-Computer Processing & Data Preparation
Fiscal year ends: December 31
Employees: 697
Held by institutions: 34.8%
Auditor: PricewaterhouseCoopers LLP
SEC CIK: 1809519

Advertisement
300 × 250